Elekta’s Gamma Knife Radiosurgery Device Cleared

The FDA has cleared Stockholm-based Elekta’s Esprit gamma knife for radiosurgery using focused beams to treat brain tumors.

The device delivers 192 beams of radiation to the smallest targets and safeguards motor, sensory and neurocognitive functions.

The gamma knife is designed as “a gentler alternative to open surgery and conventional radiotherapy” and can target the smallest and most challenging intracranial tumors and lesions with minimal effect on healthy tissue, the company said.

The Esprit knife, which previously gained a European CE mark, is already available in several markets worldwide that accept the CE mark certification.